文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

更新于 2018 年：头颈部癌症中的 18F-FDG PET/CT 和 PET/MRI。

Update 2018: 18F-FDG PET/CT and PET/MRI in Head and Neck Cancer.

机构信息

Y.S. is a Visiting Senior Research Fellow, UT Southwestern Medical Center, Dallas, TX.

K.Z. is an Associate Professor of Radiology, McMaster University, Hamilton, Ontario, Canada.

出版信息

Clin Nucl Med. 2018 Dec;43(12):e439-e452. doi: 10.1097/RLU.0000000000002247.

DOI:10.1097/RLU.0000000000002247
PMID:30394934
Abstract

There are recent advances, namely, a standardized method for reporting therapy response (Hopkins criteria), a multicenter prospective cohort study with excellent negative predictive value of F-FDG PET/CT for N0 clinical neck, a phase III multicenter randomized controlled study establishing the value of a negative posttherapy F-FDG PET/CT for patient management, a phase II randomized controlled study demonstrating radiation dose reduction strategies for human papilloma virus-related disease, and Food and Drug Administration approval of nivolumab for treatment of recurrent head and neck squamous cell carcinoma.

摘要

目前已有一些新进展，包括：一种用于报告治疗效果的标准化方法（霍普金斯标准）、一项多中心前瞻性队列研究，该研究显示 F-FDG PET/CT 对 N0 期临床颈部的阴性预测值非常高、一项 III 期多中心随机对照研究证实了治疗后 F-FDG PET/CT 阴性对患者管理的价值、一项 II 期随机对照研究证实了针对人乳头瘤病毒相关性疾病的放射剂量降低策略，以及美国食品和药物管理局批准纳武单抗用于治疗复发性头颈部鳞状细胞癌。

相似文献

[1]
Update 2018: 18F-FDG PET/CT and PET/MRI in Head and Neck Cancer.

Clin Nucl Med. 2018-12

[2]
Use of Diffusion-Weighted Imaging and F-Fluorodeoxyglucose Positron Emission Tomography Combined With Computed Tomography in the Response Assessment for (Chemo)radiotherapy in Head and Neck Squamous Cell Carcinoma.

Clin Oncol (R Coll Radiol). 2018-10-11

[3]
Response evaluation of cervical lymph nodes after chemoradiation in patients with head and neck cancer - does additional [18F]FDG-PET-CT help?

Cancer Imaging. 2020-9-29

[4]
Tumor to cervical spinal cord standardized uptake ratio (SUR) improves the reproducibility of F-FDG-PET based tumor segmentation in head and neck squamous cell carcinoma in a multicenter setting.

Radiother Oncol. 2018-7-10

[5]
Comparison of diffusion-weighted MR imaging and F Fluorodeoxyglucose PET/CT in detection of residual or recurrent tumors and delineation of their local spread after (chemo) radiotherapy for head and neck squamous cell carcinoma.

Eur J Radiol. 2020-9

[6]
Diagnosis, Staging, Radiation Treatment Response Assessment, and Outcome Prognostication of Head and Neck Cancers Using PET Imaging: A Systematic Review.

PET Clin. 2020-1

[7]
Single-Center Prospective Trial Investigating the Feasibility of Serial FDG-PET Guided Adaptive Radiation Therapy for Head and Neck Cancer.

Int J Radiat Oncol Biol Phys. 2020-11-15

[8]
Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.

Int J Radiat Oncol Biol Phys. 2015-3-1

[9]
(18)F-Fluorodeoxyglucose PET/MR Imaging in Head and Neck Cancer.

PET Clin. 2016-10

[10]
Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET.

Radiat Oncol. 2018-8-29

引用本文的文献

[1]
PET/MR for predicting extranodal extension of head and neck cancer.

Neuroradiology. 2025-5-21

[2]
Utilization of Gallium-68 Fibroblast Activation Protein Inhibitor Positron Emission Tomography (⁶⁸Ga-FAPI PET) for Head and Neck Malignancies With Neck Imaging Reporting and Data System (Ni-RADS) Correlation.

Cureus. 2025-2-4

[3]
Baseline SUVmax is correlated with tumor hypoxia and patient outcomes in nasopharyngeal carcinoma.

Sci Rep. 2024-8-30

[4]
Role of F-FDG PET/CT in Head and Neck Squamous Cell Carcinoma: Current Evidence and Innovative Applications.

Cancers (Basel). 2024-5-16

[5]
The added values of F-FDG PET/CT in differentiating cancer recurrence and osteoradionecrosis of mandible in patients with treated oral squamous cell carcinoma.

EJNMMI Res. 2023-4-3

[6]
PET/MR versus PET/CT for locoregional staging of oropharyngeal squamous cell cancer.

Acta Radiol. 2023-5

[7]
Diagnostic Accuracy of F-FDG-PET/CT and F-FDG-PET/MRI in Detecting Locoregional Recurrence of HNSCC 12 Weeks after the End of Chemoradiotherapy: Single-Center Experience with PET/MRI.

Contrast Media Mol Imaging. 2022

[8]
Molecular imaging in oncology: Current impact and future directions.

CA Cancer J Clin. 2022-7

[9]
Radiomic model for differentiating parotid pleomorphic adenoma from parotid adenolymphoma based on MRI images.

BMC Med Imaging. 2021-3-20

[10]
FDG-PET/CT and Pathology in Newly Diagnosed Head and Neck Cancer: ACRIN 6685 Trial, FDG-PET/CT cN0.

Otolaryngol Head Neck Surg. 2021-6

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索